Results of a nationwide epidemiologic survey of autosomal recessive congenital ichthyosis and ichthyosis syndromes in Japan - 11/10/19
, Ritei Uehara, MD, PhD b, Atsushi Takagi, MD, PhD c, Yumi Aoyama, MD, PhD d, Keiji Iwatsuki, MD, PhD e, Masayuki Amagai, MD, PhD f, Masaki Nagai, MD, PhD g, Yosikazu Nakamura, MD, PhD b, Yutaka Inaba, MD, PhD a, Kazuhito Yokoyama, MD, PhD a, Shigaku Ikeda, MD, PhD cAbstract |
Background |
Autosomal recessive congenital ichthyosis (ARCI) and ichthyosis syndrome (IS) are rare genetic skin disorders.
Objective |
To estimate the number of patients with ARCI and IS in Japan and clarify the clinicoepidemiologic features of these diseases.
Methods |
We performed a nationwide survey of patients treated for ARCI or IS during January 2005-December 2009. We developed diagnostic criteria and conducted a primary survey in a stratified random sample of Japanese hospitals to quantify the number of outpatients and inpatients with ARCI or IS. We performed a secondary survey of clinicoepidemiologic features in positive cases.
Results |
The estimated number of patients receiving treatment for ARCI and IS during 2005-2009 was 220 (95% confidence interval [CI] 180-260). The estimated disease distribution was as follows: 95 (95% CI 80-110) patients with nonbullous congenital ichthyosiform erythroderma, 30 (95% CI 20-40) with lamellar ichthyosis, 15 (95% CI 10-20) with harlequin ichthyosis, and 85 (95% CI 50-120) with IS.
Limitations |
Patients with a mild case of the disease might not have visited a dermatology department, potentially causing underestimation of affected patients.
Conclusion |
We report the estimated number of patients with ARCI and IS in Japan and sex differences in the age distribution.
Le texte complet de cet article est disponible en PDF.Key words : autosomal recessive congenital ichthyosis, congenital ichthyosiform erythroderma, epidemiology, harlequin ichthyosis, ichthyosis syndrome, lamellar ichthyosis, nationwide survey, nonbullous congenital ichthyosiform erythroderma
Abbreviations used : ARCI, BCIE, CI, HI, IS, LI, NBCIE
Plan
| Funding sources: Supported by Health and Labour Sciences Research grants (for research on intractable diseases) from the Ministry of Health, Labour and Welfare, Japan. |
|
| Conflicts of interest: None disclosed. |
Vol 81 - N° 5
P. 1086 - novembre 2019 Retour au numéro
Article précédent
- Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis
- Matthias Neufeld, Karen Molyneux, Karin I. Pappelbaum, Sarah Mayer-Hain, Christina von Hodenberg, Jan Ehrchen, Jonathan Barratt, Yusuke Suzuki, Cord Sunderkötter
- A cross-sectional survey and analysis of Dermatology Foundation Career Development Award recipients
- Chris Boris, George Cotsarelis, Janet A. Fairley, Bruce U. Wintroub, Kim B. Yancey
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?